CRH in chronic inflammatory stress.
Corticotropin-releasing hormone (CRH) is an important regulator of inflammation at the central level through hypothalamo-pituitary-adrenal (HPA) axis control of glucocorticoid secretion. Integrity of the HPA axis during autoimmune disease is critical in controlling the severity of inflammation, but the evidence for an HPA axis defect in the etiology of autoimmune diseases is not compelling. CRH secreted from leukocytes and neuronal terminals in peripheral tissues also plays a role in mediating inflammation. Elucidating the pathways underlying the expression of CRH, both central and peripheral, and interactions of CRH with other inflammatory mediators such as substance P, confers great potential for the development of a new generation of anti-inflammatory agents.
Jessop
D S
DS
University Research Centre for Neuroendocrinology, University of Bristol, BS2 8HW, Bristol, UK. David.Jessop@Bristol.ac.uk
Harbuz
M S
MS
Lightman
S L
SL
D000818:Animals; D002490:Central Nervous System / Q000503:physiopathology; D002908:Chronic Disease; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism*; D004198:Disease Susceptibility; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology*; D007249:Inflammation / Q000150:complications / Q000503:physiopathology*; D017933:Peripheral Nervous System / Q000503:physiopathology; D010913:Pituitary-Adrenal System / Q000503:physiopathology; D013312:Stress, Physiological / Q000150:complications / Q000503:physiopathology*
D003346:Corticotropin-Releasing Hormone